In order to evaluate whether HHT patients show a disease-specific fingerprint in the Mid-IR spectrum or not, we first tested our hypothesis with 63 genetically confirmed endoglin and ALK1 HHT patients. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.